非处方镇痛药市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按药物类型、配销通路、地区、竞争细分

2022 年，全球非处方 (OTC) 镇痛药市场估值达到 190.7 亿美元，并预计在预测期内强劲增长，预计复合年增长率 (CAGR) 为 8.00%，预计将达到2028 年将达到301.6亿美元。

介绍：

细胞穿透胜肽（CPP）代表一类能够跨细胞膜运输连接分子的胜肽。这一特性使它们成为增强治疗性蛋白质和胜肽通过细胞膜的渗透性的有前途的方法。近年来，细胞穿透胜肽（CPP）因其在跨细胞膜递送各种治疗剂方面的潜力而受到极大关注。受到塑造该行业格局的关键因素的影响，这种浓厚的兴趣正在推动全球细胞穿透胜肽市场的大幅成长。

市场概况
预测期	2024-2028
2022 年市场规模	190.7亿美元
2028 年市场规模	301.6亿美元
2023-2028 年复合年增长率	8%
成长最快的细分市场	网路药局
最大的市场	北美洲

主要市场驱动因素：

1. 人口老化和慢性病的增加：

全球非处方（OTC）镇痛药市场受到两个重要因素的影响：人口老化和慢性病的流行。老年人经常需要缓解疼痛来控制慢性病，导致对非处方镇痛药的持续需求。便利性、可近性以及避免使用强效处方药的愿望导致老年人偏好非处方镇痛药。慢性病通常会导致持续的疼痛和不适，从而推动对止痛药物（包括非处方止痛药）的持续需求。这些药物提供了便利性和可及性，无需处方，使其成为治疗与慢性病相关的日常疼痛的首选。慢性病影响各个年龄层的个人，扩大了针对慢性疼痛的非处方止痛药市场。随着人们主动控制疼痛，对慢性病的认识和教育的提高推动了对非处方止痛药的需求。例如，美国在 2021/22 学年报告了 4,998 起受伤事件，因此需要针对运动相关损伤提供有效的止痛方案。

2. 消费者意识和自我保健趋势不断增强：

消费者意识的提高和自我照护趋势对全球非处方 (OTC) 镇痛药市场产生了重大影响。这些趋势反映了消费者偏好和行为的变化，影响个人缓解疼痛和整体健康的方式。知情的消费者在网路和其他来源现成的健康资讯的鼓励下寻求了解疼痛管理方案。自我保健趋势提倡个人对健康和福祉的责任，引导个人独立处理疼痛等轻微健康问题。非处方镇痛药为消费者提供了一种方便易用的方法来缓解疼痛，无需医生处方。这些药物在药局、超市、便利商店和线上平台上随处可见。现代生活方式的特征是日程繁忙和压力增加，偶尔会导致疼痛和不适。非处方镇痛药提供快速有效的解决方案，使个人能够保持生产力和生活品质。随着消费者意识的增强，製造商可以进行有针对性的行销活动，向消费者宣传其非处方镇痛产品的好处和正确使用方法。研发的投资可以带来满足特定疼痛缓解需求的创新产品。

3. 医疗费用上涨：

医疗保健成本的增加极大地影响了全球非处方（OTC）镇痛药市场。不断上升的医疗保健费用促使个人和医疗保健系统寻求具有成本效益的解决方案来管理轻微的健康问题，包括缓解疼痛。非处方镇痛药为缓解轻度至中度疼痛提供了处方药的经济替代品。随着医疗保健成本的上升，消费者可能更喜欢非处方药，以避免与医生就诊、处方和自付费用相关的额外费用。当不需要立即就医时，不断上涨的医疗费用可能会促使人们转向非处方止痛药来缓解疼痛。这些药物提供了一种经济有效的方法来解决疼痛，可能节省资源并防止轻微疼痛升级为更严重的健康问题。非处方止痛药可能是首选，尤其是当保险计划的免赔额较高或非处方药承保范围有限时。

4、产品创新与行销：

产品创新和行销策略在推动全球非处方 (OTC) 镇痛药市场的成长中发挥关键作用。这些因素影响消费者的看法、偏好和购买决策，最终影响市场扩张。创新的配方和给药方法提高了 OTC 镇痛药缓解疼痛的有效性、速度或便利性。例如，速溶片剂、贴片、凝胶剂和喷雾剂，可满足不同消费者的喜好和需求。针对偏头痛或关节炎等特定类型的疼痛定制非处方止痛药，吸引了寻求符合其独特疼痛管理需求的解决方案的消费者。将具有镇痛特性的植物成分融入非处方药产品中，满足了寻求天然或草药替代品的注重健康的消费者的偏好。非处方止痛药的缓释功能可提供更持久的疼痛缓解，减少频繁给药的需要。

主要市场挑战：

1. 监理审查与安全问题：

监管审查和安全问题可能会阻碍全球非处方 (OTC) 镇痛药市场的成长。监管机构对非处方药执行严格的安全标准，以确保消费者的福祉。製造商必须遵守有关活性成分、剂量和潜在药物交互作用的指南。如果某些成分或配方被认为不安全，监管机构可以限制产品或将其从市场上撤下。不良事件、意外副作用或产品召回可能会削弱消费者对非处方镇痛产品的信任，导致销售下降和监管审查加强，从而阻碍市场成长。针对特定族群（例如儿童或孕妇）的年龄限製或警告可能会限制目标受众并缩小整体市场规模。全面的警告标籤也可能影响产品的使用，引起消费者的担忧。

2. 专利到期和仿製药竞争：

专利到期和仿製药竞争可能会阻碍全球非处方 (OTC) 镇痛药市场的成长。专利到期使仿製药製造商能够生产和销售该药物的同等版本，从而导致竞争加剧。仿製药的价格通常低于品牌药，随着消费者转向更实惠的选择，市场价值可能会降低。在功效和安全性方面对仿製药等效性的认知可能会影响品牌非处方镇痛药的市场份额，特别是当消费者选择较便宜的仿製药时。

主要市场趋势：

1. 个人化止痛解决方案：

个人化止痛解决方案有可能对全球非处方 (OTC) 镇痛药市场的成长产生重大影响。个人化涉及根据个人需求和偏好客製化产品，与不断变化的医疗保健和消费者趋势保持一致。客製化解决方案使非处方镇痛药物能够解决特定的疼痛类型，例如偏头痛、经痛或关节不适，满足不同的消费者需求并可能增加对专业产品的需求。个人化透过提供针对消费者独特需求而设计的产品、鼓励产品选择和品牌忠诚度来促进消费者参与。

2. 监管转变与成分审查：

监管转变和对非处方镇痛成分审查的加强影响着全球非处方 (OTC) 镇痛药市场。法规和成分评估的变化会影响产品配方、标籤和消费者认知。严格的监管要求可能会成为新进入者的进入壁垒，可能会延迟创新产品的推出并阻碍市场成长。国际监管变化可以标准化成分清单、安全标准和标籤要求，从而可能限制区域产品的差异。监管转变可能需要额外的测试和记录来证明产品的安全性和有效性，从而增加成本并推迟产品发布。成分审查可能会影响供应商关係，如果使用受限成分，则需要替代来源，从而影响供应链和产品一致性。

细分洞见：

药物类型见解：

在药物类型领域，非类固醇抗发炎药（NSAID）预计将大幅市场成长。非类固醇抗发炎药在治疗各种病症方面的多功能性、缓解疼痛的有效性以及抗发炎特性，使得非类固醇抗发炎药物对寻求非处方药止痛选择的消费者俱有吸引力。针对特定疼痛类型（例如经痛或背痛）的有针对性的行销可以吸引寻求量身定制的疼痛缓解解决方案的消费者。

最终用途见解：

零售药局部门一直在市场上占据主导地位，为消费者购买非处方止痛药提供了便利性和可近性。零售药房连锁店的广泛存在确保了快速获得止痛产品，知识渊博的药剂师提供指导和建议。零售药局的线上平台扩大了可近性，进一步促进了市场成长。

区域见解：

北美，特别是美国，在 2022 年成为非处方 (OTC) 镇痛药市场的领导者。人口众多、购买力强、慢性疼痛患病率高以及消费者的健康和保健意识有助于从而奠定了北美市场的主导地位。非处方镇痛药的自我保健趋势和便利性符合北美消费者的生活方式和偏好，进一步推动市场成长。发达的零售药房网路和电子商务基础设施提高了该地区非处方止痛药的可及性。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球非处方 (OTC) 镇痛药市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依药物类型（对乙酰氨基酚、非类固​​醇类抗发炎药 (NSAID)、水杨酸盐和其他镇痛药）
  • 按配销通路（医院药房、零售药房、网路药房）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司划分 (2022)
• 市场地图
  • 依药物类型
  • 按配销通路
  • 按地区

第 6 章：北美非处方 (OTC) 镇痛药市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依药物类型（对乙酰氨基酚、非类固​​醇类抗发炎药 (NSAID)、水杨酸盐和其他镇痛药）
  • 按配销通路（医院药房、零售药房、网路药房）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲非处方 (OTC) 止痛药市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依药物类型（对乙酰氨基酚、非类固​​醇类抗发炎药 (NSAID)、水杨酸盐和其他镇痛药）
  • 按配销通路（医院药房、零售药房、网路药房）
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第 8 章：亚太地区非处方 (OTC) 止痛药市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依药物类型（对乙酰氨基酚、非类固​​醇类抗发炎药 (NSAID)、水杨酸盐和其他镇痛药）
  • 按配销通路（医院药房、零售药房、网路药房）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲非处方 (OTC) 止痛药市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依药物类型（对乙酰氨基酚、非类固​​醇类抗发炎药 (NSAID)、水杨酸盐和其他镇痛药）
  • 按配销通路（医院药房、零售药房、网路药房）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲非处方 (OTC) 镇痛药市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依药物类型（对乙酰氨基酚、非类固​​醇类抗发炎药 (NSAID)、水杨酸盐和其他镇痛药）
  • 按配销通路（医院药房、零售药房、网路药房）
  • 按国家/地区
• MEA：国家分析
  • 南非非处方 (OTC) 止痛药
  • 沙乌地阿拉伯非处方 (OTC) 止痛药
  • 阿联酋非处方 (OTC) 镇痛药

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球非处方 (OTC) 止痛药市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT分析
  • Bayer AG.
  • Boehringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc
  • GSK plc
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Merck & Co Inc.

第 16 章：策略建议

The Global Over-the-Counter (OTC) Analgesics Market reached a valuation of USD 19.07 Billion in 2022 and is poised for robust growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 8.00% and is expected to reach USD 30.16 Billion through 2028.

Introduction:

Cell-penetrating peptides (CPPs) represent a class of peptides capable of transporting linked molecules across cellular membranes. This property makes them a promising approach for enhancing the permeability of therapeutic proteins and peptides through cellular membranes. Recent years have witnessed significant attention directed towards cell-penetrating peptides (CPPs) due to their potential in delivering various therapeutic agents across cellular membranes. This heightened interest is driving substantial growth in the global cell-penetrating peptides market, influenced by key factors shaping this industry's landscape.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 19.07 Billion
Market Size 2028	USD 30.16 Billion
CAGR 2023-2028	8%
Fastest Growing Segment	Online Pharmacies
Largest Market	North America

Key Market Drivers:

1. Rising Aging Population and Chronic Conditions:

The global over-the-counter (OTC) analgesics market is influenced by two significant factors: the aging population and the prevalence of chronic conditions. Older individuals frequently require pain relief to manage chronic conditions, leading to sustained demand for OTC analgesics. Convenience, accessibility, and a desire to avoid potent prescription medications contribute to the preference for OTC analgesics among older individuals. Chronic conditions often result in ongoing pain and discomfort, driving consistent demand for pain relief medications, including OTC analgesics. These medications offer convenience and accessibility without the need for a prescription, making them a favored choice for managing daily pain associated with chronic conditions. Chronic conditions affect individuals across various age groups, expanding the market for OTC analgesics targeting chronic pain. Heightened awareness and education about chronic conditions drive demand for OTC analgesics as individuals proactively manage their pain. The United States, for instance, reported 4,998 injuries during the academic year 2021/22, creating a need for effective pain relief options among sports-related injuries.

2. Growing Consumer Awareness and Self-Care Trends:

Increasing consumer awareness and self-care trends significantly impact the global Over-the-Counter (OTC) analgesics market. These trends reflect changing consumer preferences and behaviors, influencing how individuals approach pain relief and overall well-being. Informed consumers seek to understand pain management options, encouraged by readily available health information through the internet and other sources. Self-care trends promote personal responsibility for health and well-being, leading individuals to manage minor health issues, such as pain, independently. OTC analgesics offer a convenient and accessible means for consumers to address pain without the need for a doctor's prescription. These medications are widely available in pharmacies, supermarkets, convenience stores, and online platforms. Modern lifestyles, characterized by busy schedules and increased stress, contribute to occasional pain and discomfort. OTC analgesics offer quick and effective solutions, enabling individuals to maintain productivity and quality of life. As consumer awareness grows, manufacturers can engage in targeted marketing campaigns to educate consumers about their OTC analgesic products' benefits and appropriate usage. Investments in research and development can lead to innovative products catering to specific pain relief needs.

3. Rising Healthcare Costs:

Increasing healthcare costs significantly influence the global Over-the-Counter (OTC) analgesics market. Escalating healthcare expenses drive individuals and healthcare systems to seek cost-effective solutions for managing minor health issues, including pain relief. OTC analgesics offer affordable alternatives to prescription medications for addressing mild to moderate pain. As healthcare costs rise, consumers may prefer OTC options, avoiding additional expenses associated with doctor visits, prescriptions, and co-pays. Rising healthcare costs may prompt individuals to turn to OTC analgesics for pain relief when immediate medical attention is unnecessary. These medications provide a cost-effective means to address pain, potentially conserving resources and preventing the escalation of minor pain into more serious health issues. OTC analgesics may be preferred, especially when insurance plans have high deductibles or limited coverage for non-prescription medications.

4. Product Innovation and Marketing:

Product innovation and marketing strategies play pivotal roles in driving the growth of the global Over-the-Counter (OTC) analgesics market. These factors influence consumer perceptions, preferences, and purchasing decisions, ultimately shaping market expansion. Innovative formulations and delivery methods enhance the effectiveness, speed, or convenience of pain relief offered by OTC analgesics. Examples include fast-dissolving tablets, patches, gels, and sprays, catering to diverse consumer preferences and needs. Tailoring OTC analgesics for specific types of pain, such as migraines or arthritis, attracts consumers seeking solutions aligned with their unique pain management requirements. Incorporating botanical ingredients with analgesic properties into OTC products addresses the preferences of health-conscious consumers seeking natural or herbal alternatives. Extended-release capabilities in OTC analgesics provide longer-lasting pain relief, reducing the need for frequent dosing.

Key Market Challenges:

1. Regulatory Scrutiny and Safety Concerns:

Regulatory scrutiny and safety concerns can impede the growth of the global Over-the-Counter (OTC) analgesics market. Regulatory agencies enforce stringent safety standards for OTC medications to ensure consumer well-being. Manufacturers must adhere to guidelines regarding active ingredients, dosages, and potential medication interactions. Regulatory authorities can restrict or remove products from the market if certain ingredients or formulations are deemed unsafe. Adverse events, unexpected side effects, or product recalls can erode consumer trust in OTC analgesic products, leading to decreased sales and heightened regulatory scrutiny, hindering market growth. Age restrictions or warnings for specific populations, such as children or pregnant women, can limit the target audience and reduce the overall market size. Comprehensive warning labels may also impact product use, raising consumer concerns.

2. Patent Expirations and Generic Competition:

Patent expirations and generic competition can hinder the growth of the global Over-the-Counter (OTC) analgesics market. Patent expiration enables generic manufacturers to produce and market equivalent versions of the drug, leading to increased competition. Generic drugs are typically priced lower than their brand-name counterparts, potentially reducing the market value as consumers switch to more affordable options. The perception of generic equivalence in terms of efficacy and safety can impact the market share of brand-name OTC analgesics, particularly when consumers opt for less expensive generic versions.

Key Market Trends:

1. Personalized Pain Relief Solutions:

Personalized pain relief solutions have the potential to significantly influence the growth of the global Over-the-Counter (OTC) analgesics market. Personalization involves tailoring products to individual needs and preferences, aligning with evolving healthcare and consumer trends. Customized solutions enable OTC analgesics to address specific pain types, such as migraines, menstrual pain, or joint discomfort, meeting diverse consumer needs and potentially increasing demand for specialized products. Personalization fosters consumer engagement by offering products designed for their unique requirements, encouraging product selection and brand loyalty.

2. Regulatory Shifts and Ingredient Scrutiny:

Regulatory shifts and increased scrutiny of OTC analgesic ingredients impact the global Over-the-Counter (OTC) analgesics market. Changes in regulations and ingredient assessments influence product formulation, labeling, and consumer perception. Stringent regulatory requirements may serve as barriers to entry for new entrants, potentially delaying the introduction of innovative products and hindering market growth. International regulatory shifts can standardize ingredient lists, safety standards, and labeling requirements, potentially limiting regional product variations. Regulatory shifts may necessitate additional testing and documentation to prove product safety and efficacy, increasing costs and delaying product launches. Ingredient scrutiny can affect supplier relationships, requiring alternative sources if restricted ingredients are used, impacting supply chains and product consistency.

Segmental Insights:

Drug Type Insights:

Within the drug type segment, Nonsteroidal Anti-inflammatory Drugs (NSAIDs) are expected to witness substantial market growth. Versatility in addressing various conditions, effectiveness in providing pain relief, and anti-inflammatory properties contribute to the appeal of NSAIDs among consumers seeking OTC pain relief options. Targeted marketing for specific pain types, such as menstrual pain or back pain, can attract consumers seeking tailored pain relief solutions.

End Use Insights:

The Retail Pharmacies segment has been dominant in the market, offering convenience and accessibility for consumers to purchase OTC analgesics. The widespread presence of retail pharmacy chains ensures quick access to pain relief products, with knowledgeable pharmacists providing guidance and recommendations. Online platforms of retail pharmacies expand accessibility, further contributing to market growth.

Regional Insights:

North America, particularly the United States, has been the leader in the Over-the-Counter (OTC) Analgesics Market in 2022. A large population, strong purchasing power, high prevalence of chronic pain conditions, and consumer awareness of health and wellness contribute to the dominance of North America in the market. The self-care trend and the convenience of OTC analgesics align with the lifestyle and preferences of North American consumers, further driving market growth. Well-developed retail pharmacy networks and e-commerce infrastructure enhance the accessibility of OTC analgesics in the region.

Key Market Players

• Bayer AG.
• Boehringer Ingelheim International GmbH
• Johnson & Johnson Services Inc
• GSK plc
• Pfizer Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Merck & Co Inc.

Report Scope:

In this report, the Global Over-the-Counter (OTC) Analgesics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Over-the-Counter (OTC) Analgesics Market, By Drug Type:

• Acetaminophen
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Salicylates
• Other Analgesics

Over-the-Counter (OTC) Analgesics Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Over-the-Counter (OTC) Analgesics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Over-the-Counter (OTC) Analgesics Market.

Available Customizations:

• Global Over-the-Counter (OTC) Analgesics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Over-the-Counter (OTC) Analgesics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
  • 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Drug Type
  • 5.3.2 By Distribution Channel
  • 5.3.3 By Region

6. North America Over-the-Counter (OTC) Analgesics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
  • 6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Over-the-Counter (OTC) Analgesics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Type
      • 6.3.1.2.2. By Distribution Channel
  • 6.3.2. Canada Over-the-Counter (OTC) Analgesics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Type
      • 6.3.2.2.2. By Distribution Channel
  • 6.3.3. Mexico Over-the-Counter (OTC) Analgesics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Type
      • 6.3.3.2.2. By Distribution Channel

7. Europe Over-the-Counter (OTC) Analgesics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
  • 7.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Over-the-Counter (OTC) Analgesics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Type
      • 7.3.1.2.2. By Distribution Channel
  • 7.3.2. Germany Over-the-Counter (OTC) Analgesics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Type
      • 7.3.2.2.2. By Distribution Channel
  • 7.3.3. United Kingdom Over-the-Counter (OTC) Analgesics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Type
      • 7.3.3.2.2. By Distribution Channel
  • 7.3.4. Italy Over-the-Counter (OTC) Analgesics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Type
      • 7.3.4.2.2. By Distribution Channel
  • 7.3.5. Spain Over-the-Counter (OTC) Analgesics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Type
      • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
  • 8.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Over-the-Counter (OTC) Analgesics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Type
      • 8.3.1.2.2. By Distribution Channel
  • 8.3.2. India Over-the-Counter (OTC) Analgesics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Type
      • 8.3.2.2.2. By Distribution Channel
  • 8.3.3. Japan Over-the-Counter (OTC) Analgesics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Type
      • 8.3.3.2.2. By Distribution Channel
  • 8.3.4. South Korea Over-the-Counter (OTC) Analgesics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Type
      • 8.3.4.2.2. By Distribution Channel
  • 8.3.5. Australia Over-the-Counter (OTC) Analgesics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Type
      • 8.3.5.2.2. By Distribution Channel

9. South America Over-the-Counter (OTC) Analgesics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
  • 9.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Over-the-Counter (OTC) Analgesics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Type
      • 9.3.1.2.2. By Distribution Channel
  • 9.3.2. Argentina Over-the-Counter (OTC) Analgesics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Type
      • 9.3.2.2.2. By Distribution Channel
  • 9.3.3. Colombia Over-the-Counter (OTC) Analgesics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Type
      • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Over-the-Counter (OTC) Analgesics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
  • 10.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Over-the-Counter (OTC) Analgesics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Type
      • 10.3.1.2.2. By Distribution Channel
  • 10.3.2. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Type
      • 10.3.2.2.2. By Distribution Channel
  • 10.3.3. UAE Over-the-Counter (OTC) Analgesics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Type
      • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Over-the-Counter (OTC) Analgesics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Bayer AG.
  • 15.6.2 Boehringer Ingelheim International GmbH
  • 15.6.3 Johnson & Johnson Services Inc
  • 15.6.4 GSK plc
  • 15.6.5 Pfizer Inc.
  • 15.6.6 Sanofi
  • 15.6.7 Sun Pharmaceutical Industries Ltd.
  • 15.6.8 Takeda Pharmaceutical Company Limited
  • 15.6.9 AstraZeneca
  • 15.6.10 Merck & Co Inc.

16. Strategic Recommendations